West Pharmaceutical Services ( (WST) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
West Pharmaceutical Services’ shares experienced unusual movement as the company reported strong Q4 results, surpassing revenue and profit expectations with $748.8 million in revenue. However, the stock is under pressure due to a cautious full-year 2025 forecast, with net sales projected between $2.88 billion and $2.91 billion, falling short of the $3.04 billion consensus. This shortfall is partly due to a $75 million foreign currency exchange headwind. Additionally, the adjusted-diluted EPS is expected to be between $6.00 and $6.20, reflecting similar currency impacts. Analysts have adjusted their price targets in response to these mixed signals, acknowledging the company’s recent successes but also the potential challenges ahead.
More about West Pharmaceutical Services
YTD Price Performance: -1.55%
Average Trading Volume: 487,790
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $23.34B
For further insights into WST stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.